Kansal A[au] - Search Results

Year	Number of Results
1997	1
2000	3
2001	1
2002	1
2003	1
2004	1
2005	3
2006	6
2007	3
2008	5
2009	3
2010	5
2011	2
2012	7
2013	7
2014	10
2015	6
2016	9
2017	4
2018	12
2019	10
2020	13
2021	20
2022	18
2023	4

1

Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone.

Ben-Joseph R, Bell JA, Brixner D, Kansal A, Paramore C, Chitnis A, Holly P, S Burgoyne D. Ben-Joseph R, et al. Among authors: kansal a. J Manag Care Spec Pharm. 2016 Apr;22(4):358-66. doi: 10.18553/jmcp.2016.22.4.358. J Manag Care Spec Pharm. 2016. PMID: 27023689

2

Pyoderma gangrenosum.

Saigal R, Singh Y, Mittal M, Kansal A, Maharia HR. Saigal R, et al. Among authors: kansal a. J Assoc Physicians India. 2010 Jun;58:378-83. J Assoc Physicians India. 2010. PMID: 21125780 Review.

3

Endovascular treatment of femoro-popliteal lesions.

Kansal A, Long CA, Patel MR, Jones WS. Kansal A, et al. Clin Cardiol. 2019 Jan;42(1):175-183. doi: 10.1002/clc.23098. Epub 2018 Dec 4. Clin Cardiol. 2019. PMID: 30324655 Free PMC article. Review.

4

Cost-effectiveness analysis of empagliflozin versus sitagliptin as second-line therapy for treatment in patients with type 2 diabetes in the United States.

Reifsnider O, Kansal A, Pimple P, Aponte-Ribero V, Brand S, Shetty S. Reifsnider O, et al. Among authors: kansal a. Diabetes Obes Metab. 2021 Mar;23(3):791-799. doi: 10.1111/dom.14268. Epub 2020 Dec 15. Diabetes Obes Metab. 2021. PMID: 33236481 Free PMC article.

5

Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease.

Reifsnider OS, Kansal AR, Gandhi PK, Cragin L, Brand SB, Pfarr E, Fahrbach K, Ustyugova A. Reifsnider OS, et al. Among authors: kansal ar. BMJ Open Diabetes Res Care. 2021 May;9(1):e001313. doi: 10.1136/bmjdrc-2020-001313. BMJ Open Diabetes Res Care. 2021. PMID: 33941549 Free PMC article.

6

Muir-Torre syndrome.

Kansal A, Aggarwal S, Gupta D. Kansal A, et al. Indian J Dermatol Venereol Leprol. 2014 Jul-Aug;80(4):356-8. doi: 10.4103/0378-6323.136928. Indian J Dermatol Venereol Leprol. 2014. PMID: 25035371 Free article. No abstract available.

7

Fat embolism syndrome.

Saigal R, Mittal M, Kansal A, Singh Y, Kolar PR, Jain S. Saigal R, et al. Among authors: kansal a. J Assoc Physicians India. 2008 Apr;56:245-9. J Assoc Physicians India. 2008. PMID: 18702388 Review.

8

Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States.

Borer JS, Kansal AR, Dorman ED, Krotneva S, Zheng Y, Patel HK, Tavazzi L, Komajda M, Ford I, Böhm M, Kielhorn A. Borer JS, et al. Among authors: kansal ar. J Manag Care Spec Pharm. 2016 Sep;22(9):1064-71. doi: 10.18553/jmcp.2016.22.9.1064. J Manag Care Spec Pharm. 2016. PMID: 27579829

9

Cerebral Amebiasis: An Uncommon Cerebral Abscess.

Varghese V, Kansal A, Bhardwaj S, Sharma A. Varghese V, et al. Among authors: kansal a. Ann Indian Acad Neurol. 2021 May-Jun;24(3):445-447. doi: 10.4103/aian.AIAN_583_20. Epub 2021 May 21. Ann Indian Acad Neurol. 2021. PMID: 34447021 Free PMC article. No abstract available.

10

Raynaud's phenomenon.

Saigal R, Kansal A, Mittal M, Singh Y, Ram H. Saigal R, et al. Among authors: kansal a. J Assoc Physicians India. 2010 May;58:309-13. J Assoc Physicians India. 2010. PMID: 21117349 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results